Shots: The approval is based on efficacy and safety data from the P-III LIBERTY 1 & 2 studies assessing Myfembree (relugolix 40 mg, estradiol 1 mg & norethindrone acetate 0.5 […]readmore
Tags : Heavy Menstrual Bleeding
Shots: The FDA’s approval is based on CLARITY study assessing Cerene in 242 patients with excessive menstrual bleeding The CLARITY study results: @12mos. reduction in menstrual bleeding; m-pain score (0-2/10); […]readmore